DNA X SONM Stock
DNA X Price Chart
DNA X SONM Financial and Trading Overview
| DNA X stock price | 3.02 USD |
| Previous Close | 3.16 USD |
| Open | 3.11 USD |
| Bid | 2.22 USD x 200 |
| Ask | 4.03 USD x 200 |
| Day's Range | 3 - 3.12 USD |
| 52 Week Range | 2.52 - 16.97 USD |
| Volume | 3.54K USD |
| Avg. Volume | 21.31K USD |
| Market Cap | 4.47M USD |
| Beta (5Y Monthly) | 1.856 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -8.34 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
SONM Valuation Measures
| Enterprise Value | 6.2M USD |
| Trailing P/E | N/A |
| Forward P/E | 3.5714288 |
| PEG Ratio (5 yr expected) | 0.25 |
| Price/Sales (ttm) | -0.3990523 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | -0.554 |
| Enterprise Value/EBITDA | -1.783 |
Trading Information
DNA X Stock Price History
| Beta (5Y Monthly) | 1.856 |
| 52-Week Change | -76.71% |
| S&P500 52-Week Change | 15.74% |
| 52 Week High | 16.97 USD |
| 52 Week Low | 2.52 USD |
| 50-Day Moving Average | 3.49 USD |
| 200-Day Moving Average | 4.4 USD |
SONM Share Statistics
| Avg. Volume (3 month) | 21.31K USD |
| Avg. Daily Volume (10-Days) | 10.04K USD |
| Shares Outstanding | 1.49M |
| Float | 1.23M |
| Short Ratio | 1.65 |
| % Held by Insiders | 34.76% |
| % Held by Institutions | 5.93% |
| Shares Short | 21.01K |
| Short % of Float | 1.67% |
| Short % of Shares Outstanding | 1.40% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:18 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 54.16% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -18.66% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | -11190000 USD |
| Revenue Per Share (ttm) | -9.617 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | -845000 USD |
| EBITDA | -3479000 USD |
| Net Income Avi to Common (ttm) | -10300000 USD |
| Diluted EPS (ttm) | -8.34 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 900K USD |
| Total Cash Per Share (mrq) | 0.61 USD |
| Total Debt (mrq) | 2.4M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.567 |
| Book Value Per Share (mrq) | -0.828 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -14505000 USD |
| Levered Free Cash Flow (ttm) | -7707250 USD |
Profile of DNA X
| Country | United States |
| State | CA |
| City | San Diego |
| Address | 4445 Eastgate Mall |
| ZIP | 92121 |
| Phone | 650 378 8100 |
| Website | https://ir.dna-x.global |
| Industry | Capital Markets |
| Sector(s) | Financial Services |
| Full Time Employees | 4 |
DNA X, Inc. provides cryptocurrency trading services worldwide. The company operates a cryptocurrency trading platform that allows users to trade and swap cryptocurrencies for other cryptocurrencies or cash-equivalent currencies. It markets its services through word of mouth and earned media on social media platforms. The company serves individual cryptocurrency traders. The company was formerly known as Sonim Technologies, Inc. and changed its name to DNA X, Inc. in January 2026. DNA X, Inc. was incorporated in 1999 and is headquartered in San Diego, California.
Q&A For DNA X Stock
What is a current SONM stock price?
DNA X SONM stock price today per share is 3.02 USD.
How to purchase DNA X stock?
You can buy SONM shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for DNA X?
The stock symbol or ticker of DNA X is SONM.
Which industry does the DNA X company belong to?
The DNA X industry is Capital Markets.
How many shares does DNA X have in circulation?
The max supply of DNA X shares is 1.49M.
What is DNA X Price to Earnings Ratio (PE Ratio)?
DNA X PE Ratio is now.
What was DNA X earnings per share over the trailing 12 months (TTM)?
DNA X EPS is -8.34 USD over the trailing 12 months.
Which sector does the DNA X company belong to?
The DNA X sector is Financial Services.
DNA X SONM included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
25981.57 USD — |
-0.78
|
7.07B USD — | 25943.31 USD — | 26172.12 USD — | — - | 7.07B USD — |
|
US Tech Telecommunications
IXTC
US
|
532.26 USD — |
-1.92
|
— — | 531.41 USD — | 542.95 USD — | — - | — — |
- {{ link.label }} {{link}}
